The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
Open accessAbstract
Cell line drug screening datasets can be utilized for a range of different drug discovery applications from drug biomarker discovery to building translational models of drug response. Previously, we described three separate methodologies to (1) correct for general levels of drug sensitivity to enable drug-specific biomarker discovery, (2) predict clinical drug response in patients and (3) associate these predictions with clinical features to perform in vivo drug biomarker discovery. Here, we unite and update these methodologies into one R package (oncoPredict) to facilitate the development and adoption of these tools. This new OncoPredict R package can be applied to various in vitro and in vivo contexts for drug and biomarker discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,183
Geeleher, P., Cox, N., & Huang, R. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107468 · Cited by 2,458
Self-citationA Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Geeleher, P., Cox, N. J., & Huang, R. S. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r47 · Cited by 890
Self-citationHarnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Seashore-Ludlow, B., Rees, M. G., Cheah, J. H., Cokol, M., Price, E. V., Coletti, M. E., Jones, V., Bodycombe, N. E., Soule, C. K., Gould, J., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0235 · Cited by 813
A community effort to assess and improve drug sensitivity prediction algorithms
Community, N. D., Costello, J. C., Heiser, L. M., Georgii, E., Gönen, M., Menden, M. P., Wang, N. J., Bansal, M., Ammad-ud-din, M., Hintsanen, P., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2877 · Cited by 772
Machine learning approaches to drug response prediction: challenges and recent progress
Adam, G., Rampášek, L., Safikhani, Z., Smirnov, P., Haibe-Kains, B., & Goldenberg, A. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0122-1 · Cited by 425
Ali, M., & Aittokallio, T. (2019) · Biophysical Reviews · doi:10.1007/s12551-018-0446-z · Cited by 207
Jang, I. S., Neto, E. C., Guinney, J., Friend, S. H., & Margolin, A. A. (2014) · PubMed · Cited by 204
Geeleher, P., Zhang, Z., Wang, F., Gruener, R. F., Nath, A., Morrison, G., Bhutra, S., Grossman, R. L., & Huang, R. S. (2017) · Genome Research · doi:10.1101/gr.221077.117 · Cited by 161
Self-citationKoti, M., Gooding, R. J., Nuin, P. A. S., Haslehurst, A., Crane, C. A., Weberpals, J. I., Childs, T. J., Bryson, P., Dharsee, M., Evans, K. G., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-549 · Cited by 126
Paltun, B. G., Mamitsuka, H., & Samuel Kaski, A. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz153 · Cited by 78
Computational models for predicting drug responses in cancer research
Azuaje, F. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw065 · Cited by 59
Jang, I. S., Neto, E. C., Guinney, J., Friend, S. H., & Margolin, A. A. (2013) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814583220_0007 · Cited by 57
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
Lin, Y., Liau, J., Yu, S.-C., Ou, D., Lin, L., Tseng, L., Chang, Y., Yeh, K., & Cheng, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050701 · Cited by 52
Geeleher, P., Cox, N. J., & Huang, R. S. (2016) · Genome biology · doi:10.1186/s13059-016-1050-9 · Cited by 47
Self-citationMore than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens
Ling, A. L., Gruener, R. F., Fessler, J. L., & Huang, R. S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.014 · Cited by 42
Self-citationSchätzle, L.-K., Esfahani, A. H., & Schuppert, A. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007803 · Cited by 20
Gruener, R. F., Ling, A. L., Chang, Y.-F., Morrison, G., Geeleher, P., Greene, G. L., & Huang, R. S. (2021) · Cancers · doi:10.3390/cancers13040885 · Cited by 17
Self-citation
Cited by
Zou, Y., Xie, J., Zheng, S., Liu, W., Tang, Y., Tian, W., Deng, X., Wu, L., Zhang, Y., Wong, C.-W., et al. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106936 · Cited by 426
Li, Y., Jiang, M., Aye, L., Luo, L., Zhang, Y., Xu, F., Wei, Y., Peng, D., He, X., Gu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45340-w · Cited by 71
Wu, X., Zhang, S., Zhang, Z., He, Z., Xu, Z., Wang, W., Jin, Z., You, J., Guo, Y., Zhang, L., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00670-2 · Cited by 43
Zhang, X., Xiao, Q., Zhang, C., Zhou, Q., & Xu, T. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18262 · Cited by 14
An, H., Fang, W., Chen, H., Huang, W., Liu, H., Zhang, Z., Zhao, H., Zhang, Y., Zhao, M., Qiu, J., et al. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108929 · Cited by 6
Metadata
- Authors
- Maeser, D., Gruener, R. F., & Huang, R. S.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-15
- Volume
- 22
- Issue
- 6
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W3182293965
- Cited by
- 1,791
- References
- 20
- FWCI
- 121.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.